Amylase2
Catalytic Methods, Amylase. 510(k) K210633, from Abbott Ireland Diagnostics Division (Longsford, IE). Product code JFJ, class 2.
As of Nov 18, 2026, K210633 is an FDA 510(k) held by Abbott Ireland Diagnostics Division, substantially equivalent on May 26, 2022 after 449 days, with no recalls tied to it in FDA's recall database.
- Review time: 449 days
- Recalls: 0
Indications for use
As the 510(k) summary states them, read from FDA's summary PDFThe Amylase2 assay is used for the quantitation of amylase in human serum, plasma, or urine on the ARCHITECT c System. The Amylase2 assay is to be used primarily as an aid in the diagnosis and treatment of pancreatitis (inflammation of the pancreas).
Predicate devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- AmyK981653 · Abbott Laboratories · Aug 28, 1998
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 3, 2021
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1070
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files